Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
Molecular Imaging and Biology|August 29, 2020
Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) ConjugatesSebastian Martin, Stephan Maus, Tobias Stemler, et al.
EJNMMI Research|May 26, 2020
Neuron-specific enolase has potential value as a biomarker for [18F]FDG/[68Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patientsFlorian Rosar, Kalle Ribbat, Martin Ries, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2020
Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing 177Lu-PSMA-617 radioligand therapyFadi Khreish, Niklas Kochems, Florian Rosar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2002
Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcomeMichael J Reinhardt, Ingo Brink, Alexius Y Joe, et al.
Pharmaceutics|June 2, 2021
Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor PrognosisFlorian Rosar, Jonas Krause, Mark Bartholomä, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2021
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)Fadi Khreish, Zaidoon Ghazal, Robert J Marlowe, et al.
EJNMMI Physics|May 5, 2021
Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapyFlorian Rosar, Niklas Schön, Hendrik Bohnenberger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2011
The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effectsHojjat Ahmadzadehfar, Marianne Muckle, Amir Sabet, et al.
Clinical Imaging|June 30, 2007
Single- vs. dual-head SPECT for detection of myocardial ischemia and viability in a large study populationJan Bucerius, Alexius Y Joe, Ina Lindstaedt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2015
Specific efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in advanced neuroendocrine tumours of the small intestineAmir Sabet, Kristina Dautzenberg, Torjan Haslerud, et al.
Pageof 16